首页>
外国专利>
Enteric coated oral pharmaceutical to erode kidney stones
Enteric coated oral pharmaceutical to erode kidney stones
展开▼
机译:肠溶性口服药物侵蚀肾结石
展开▼
页面导航
摘要
著录项
相似文献
摘要
A treatment protocol by which a renal stone patient is administered a chelating agent, generally once a day and preferably by mouth, during a treatment phase and is later administered the same chelating agent once a week, during a “maintenance” phase. The chelating agent is most preferably ethylene diamine tetraacetic acid (EDTA) and may be provided in a dosage form having an enteric coating and at least one external cathode and at least one external anode to create a galvanic current upon contact of the dosage form with the patient's intestinal contents.
展开▼